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Abstract
Synonymous codon replacement can change protein structure and function, indicating that protein structure depends on
DNA sequence. During heterologous protein expression, low expression or formation of insoluble aggregates may be
attributable to differences in synonymous codon usage between expression and natural hosts. This discordance may be
particularly important during translation of the domain boundaries (link/end segments) that separate elements of higher
ordered structure. Within such regions, ribosomal progression slows as the ribosome encounters clusters of infrequently
used codons that preferentially encode a subset of amino acids. To replicate the modulation of such localized translation
rates during heterologous expression, we used known relationships between codon usage frequencies and secondary
protein structure to develop an algorithm (‘‘codon harmonization’’) for identifying regions of slowly translated mRNA that
are putatively associated with link/end segments. It then recommends synonymous replacement codons having usage
frequencies in the heterologous expression host that are less than or equal to the usage frequencies of native codons in the
native expression host. For protein regions other than these putative link/end segments, it recommends synonymous
substitutions with codons having usage frequencies matched as nearly as possible to the native expression system. Previous
application of this algorithm facilitated E. coli expression, manufacture and testing of two Plasmodium falciparum vaccine
candidates. Here we describe the algorithm in detail and apply it to E. coli expression of three additional P. falciparum
proteins. Expression of the ‘‘recoded’’ genes exceeded that of the native genes by 4- to 1,000-fold, representing levels
suitable for vaccine manufacture. The proteins were soluble and reacted with a variety of functional conformation-specific
mAbs suggesting that they were folded properly and had assumed native conformation. Codon harmonization may further
provide a general strategy for improving the expression of soluble functional proteins during heterologous expression in
hosts other than E. coli.
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Introduction
Changes to protein structure and function that occur after
synonymous codon replacement indicate that protein structure is
DNA sequence dependent. Synonymous codon substitutions that
change codon usage frequencies from infrequent to frequent usage
in regions of slow mRNA translation can deleteriously affect
enzyme activity [1]. Conversely, synonymous substitutions that
introduce rare codons into regions predicted to contain high
frequency codons show altered substrate specificities [2]. Thus,
contrary to conventional thinking, synonymous codon substitu-
tions may not always be silent; changing codon usage frequency
affects protein structure and function, and the frequency with
which codons are used imparts vital information for the
development of secondary and tertiary protein structure.
Species-specific disparities in codon usage are frequently cited as
the cause for failures in recombinant gene expression by
heterologous expression hosts. Such failures include lack of
expression, or the expression of protein that is non-functional or
insoluble, or protein that is truncated owing to proteolysis or
premature termination of translation [3–5]. All but the last of these
failures are attributable to misfolded protein. In Escherichia coli as
well as eukaryotic species, nascent proteins fold co-translationally
within the ribosomal tunnel, which is both a protective
environment within which secondary structure begins to form
[6–8], and a dynamic environment that influences nascent protein
structure [9–12]. Within the ribosomal tunnel, subtle variations in
the rate of mRNA translation may play a key role in developing
secondary structure in the nascent protein. Translation is not a
steady state process, rather it occurs in pulses, as can be observed
from ribosomal pausing [13] and even ribosome stacking, on
specific stretches of mRNA [14]; these temporal changes in
translational rate have been shown to depend on relative tRNA
levels [15].
tRNA isoacceptor abundance and isoacceptor usage frequencies
are directly related for naturally occurring proteins from E. coli as
well as from other organisms [16–19], and there is evidence that
protein secondary structure is related to tRNA usage frequencies
PLoS ONE | www.plosone.org 1 May 2008 | Volume 3 | Issue 5 | e2189[20], although this concept is controversial [21]. Comparative
analysis of E. coli gene sequences and their respective protein
structures show that amino acid sequences encoded by more
frequently used codons are associated with highly ordered
structural elements such as alpha helices, while sequences
containing clusters of less frequently used codons tend to be
associated with the protein domain boundaries (link/end seg-
ments) that separate such elements [22]. That analysis also showed
that the link/end segments tend to be populated with amino acids
that have bulky hydrophobic side chains or side chains that can
hydrogen bond to the peptide backbone. When such residues
appear in link/end segments, they tend to be encoded by
infrequently-used codons. Therefore, the positioning of clusters
of relatively high and low abundance codons on mRNA transcripts
may be a purposeful rather than a random occurrence [23]. The
idea that link/end segments, which separate elements of higher
order protein structure, are encoded by clusters of low-usage
frequency codons leads to the hypothesis that slow translational
progression (i.e., ‘‘pausing’’) through such regions of mRNA would
allow the preceding nascent structural element to fold, at least
partially, within the environment of the ribosomal tunnel prior to
initiation of synthesis of the next structural element. Such a
temporal control mechanism would minimize the interaction
between partially folded nascent polypeptides in the cytosol, an
event which can lead to degradation, or aggregation and
precipitation.
Based on these concepts-that protein synthesis and folding in E.
coli is co-translational and that nucleotide sequence-dependent
modulation of translation kinetics might influence nascent
polypeptide folding-we developed a strategy to ‘‘recode’’ target
gene sequences for heterologous expression in E. coli by
substituting the native codons with synonymous ones having the
same or similar usage frequencies in the expression host. In this
approach, termed ‘‘codon harmonization’’, synonymous codons
from E. coli were selected that match as closely as possible the
codon usage frequency used in the native gene, unless empirical
structure calculations show that the codons are associated with
putative link/end segments and therefore should be translated
slowly. Such regions were recoded by selecting the closest
matching synonymous E. coli codon having a usage frequency
equal to or less than that of its respective isoacceptor codon’s usage
frequency in the native gene’s host.
Disharmony between codon usage patterns for Plasmodium
falciparum malaria parasite target genes and E. coli has proven
particularly challenging for heterologous expression in E. coli
owing to the 80% AT bias in the structural genes from P.
falciparum [24]. Previously, we showed that codon harmonization
can overcome this challenge. FMP003[25], which was the result
of a single codon change made in one predicted link/end
segment, and LSA-NRC
H [26] for which the gene fragment was
fully codon harmonized, were both manufactured under cGMP
conditions and have progressed through pre-clinical or clinical
evaluation as vaccine candidates. In those reports, we empha-
sized manufacture and evaluation of the products, but the details
of the algorithm were not described sufficiently to allow
replication. In this current work we explain the algorithm in
detail, and apply it to the expression of the codon harmonized
gene sequences for three additional malaria vaccine candidates,
namely MSP142 (FVO), MSP142 (3D7) and MSP142 (Camp). In
all cases, both protein yield and protein solubility improved
significantly. Protein yields were 3–12 mg purified protein/g wet
cell paste. This increase in yield of soluble protein was critical, as
it enabled these antigen candidates to be developed for clinical
testing as malaria vaccines.
Results
Codon Harmonization Algorithm
The identification of transcript regions that are likely to
promote ribosomal pausing requires a means to predict such
segments. Application of our algorithm shows a striking example
of a region of the FVO allele of the MSP142 gene fragment that
was calculated to be a link/end segment (Fig. 1, top line). Nine of
the 20 amino acids shown in this diagram are encoded by tRNA
isoacceptor codons used 15% of the time or less in P. falciparum,
where the summation of synonymous codons that could encode
each residue equals 100%. Among these, four (I141, Y151, L152,
P153) belong to the group of ten residues that tend to populate
link/end segments of E. coli proteins having known structure and
they were used at the rate of 11% of the time or less. I141 was
included in the link/end group because it lies within 14 residues of
the tricodon Y151-P153 and thus fits the criteria of the space
parameter described by Thanaraj [20]. Although I158 satisfies the
criterion of being among these ten residues and fits the space
parameter, its isoacceptor usage frequency in the native expression
host is greater than 25%; therefore this residue was not calculated
to be part of the link/end segment. Introduction of the native P.
falciparum MSP142 gene sequence into E. coli resulted in a dramatic
shift in codon usage frequencies within this region (compare first
and second lines, respectively). Of the nine low frequency codons
identified in the first line, five were shifted to higher usage
frequencies (second line); I141 and Y151 are among these. In
addition several codons, namely Q145, N148, Y154, L155, and
N157, are used at high frequency in the native host (first line) but
were used at low frequency in E. coli (second line). The usage
frequency for the residue P153 (CCC) dropped from 11% in P.
falciparum to 0.1% in E. coli. Following full codon harmonization of
this segment for expression in E. coli (i.e., addressing the frequency
of codon usage at each residue), codon usage patterns for
heterologous expression (third line) were in good agreement with
those of the gene in its native host (compare first and third line),
e.g. with the usage rate for P153 increasing to 8% as compared to
11% in P. falciparum. A table showing the full procedure for
application of the codon harmonization algorithm for this region
of FVO strain MSP142 has been included in the Supplementary
Materials (Table S1). As described below, our initial studies
evaluated the utility of this codon harmonization algorithm by
focusing on this region of the gene because, of all of the putative
regions of slowly translated mRNA that were identified, this was
the most discordant in its codon usage pattern.
Single Codon Application of Codon Harmonization
Initially, we wanted to test the value of this approach by
focusing only on a limited section of sequence that should
comprise a region of slow translation and whose usage frequency
during heterologous expression would be strongly discordant. We
determined that the region of the FVO allele of the MSP142 gene
fragment shown in Fig 1 met this requirement, and changed the
codon for I141 (ATCRATA) to test the strategy (Fig. 1, compare
first and fourth line; the shaded box on the AA residue line
identifies this residue). E. coli transformed with the altered gene
expressed significantly more protein (designated FMP003) than
was obtained from the wild type gene. Although, we could not
detect expression of the FMP003 protein directly in cell lysates on
gels stained with Coomassie Blue (Fig 2A), it was readily detected
by western blotting whereas expression of protein from the wild
type gene was not (Fig 2B). The purified protein yield for FMP003
was 70 mg/g of wet cell paste (Fig. 2C, Table 1). No protein could
be isolated from bacteria expressing the wild type gene fragment
Harmonization of Expression
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to be soluble based on its presence in the supernatant fraction after
centrifugation at 100,0006g for 1 h (data not shown). The details
of using the Codon Harmonization Algorithm to generate a
recommended sequence for the FMP003 gene are given in Table
S1.
Full Gene Codon Harmonization
The algorithm was further tested by preparing a ‘‘fully
harmonized’’ MSP142 (FVO) gene fragment (designated
FMP010), which was completely recoded according to the
harmonization approach described in ‘‘Materials and Methods.’’
The value for len/30 was calculated to be 11 and setting the
algorithm’s reference value for infrequent codon usage in P.
falciparum to 11% predicted seventeen discrete link/end segments.
Setting this reference value to 10.9% predicted only six link/end
segments. Densitometry of the gel shown in Fig. 3 shows that after
induction with IPTG, MSP142 expression level from FMP010
exceeded levels from wild type sequence by at least 100-fold, and
the purified protein yield was 4 mg/g wet cell paste (Table 1).
Protein in the cell lysate after microfluidization was fully soluble in
the presence of 0.3% sarkosyl; it remained in the supernatant
fraction after sequentially centrifuging at 30,000 and 100,0006g
for 1 h (Fig. 4, f1 and f3, respectively), and was absent from the
corresponding pellets (Fig 4, f2 and f4, respectively). The details of
using the Codon Harmonization Algorithm to generate a
recommended sequence for the FMP010 gene are given in Table
S1.
We applied the same algorithm to the expression of MSP142
(3D7) and MSP142 (Camp), which are alternative alleles to
MSP142 FVO. The len/30 values for MSP142 (3D7) was equal to
12, and setting the reference value for infrequent codon usage to
11% predicted seventeen discrete link/end segments. Setting this
reference value to 10.9% predicted only six link/end segments.
Three hours after IPTG induction, expression levels of codon
harmonized MSP142 (3D7) from pET(AT) MSP142 3D7.2 were
much higher than from the native sequence (Fig. 5A, WT and CH,
respectively, lanes 3), and product yield increased four-fold, from
0.8 mg/g wet cells for the native sequence to 3.0 mg/g wet cells
from the codon harmonized sequence (Fig 5A, Table 1). Basal
levels of expression prior to induction are shown in lanes marked
U (un-induced cells).
The Camp allele of MSP142 is a natural chimera of the FVO
and 3D7 alleles. The FVO and 3D7 alleles have different protein
sequences (58% identity) [27] within the N-terminal 300 residues
of the protein, known as MSP133, but differ only by four amino
acids within the mature C-terminal 96 amino acid fragment
known as MSP119 (Q14/ E14, K61/T61, N70/S70, and G71/
R71, respectively; numbering relative to the MSP119 fragment).
The Camp allele is identical to the 3D7 allele within the MSP133
domain and the N-terminal 80% of MSP119, including E14, but
changes to FVO (K61, N70, and G71) for the C-terminal 20% of
MSP119. The len/30 values for MSP142 (Camp) was equal to 12,
and setting the reference value for infrequent codon usage to 11%
predicted nineteen discrete link/end segments, while setting it to
10.9% or less identified only six such regions. Expression levels for
codon harmonized MSP142 Camp.2, at 12.0 mg/g wet cells
(Fig 5B, Table 1) were very high; we were not able to express wild
type MSP142 (Camp) in E. coli (Table 1).
Expression of the codon harmonized LSA-NRC
H malaria
vaccine candidate, which has been described elsewhere [26], has
proven to be the best approach, to date, for production of this
Figure 1. Comparison of Codon Usage Frequencies in the Native MSP142 (FVO) and Recoded Sequences as a Function of Expression
Host, for either native P. falciparum or E. coli expression. Amino acid segment of MSP142 (FVO) sequence is shown (residue # 140–159) with
the codon usage frequencies rounded to the nearest 10%. The shaded residue at I(141) was targeted for synonymous replacement in FMP003.
doi:10.1371/journal.pone.0002189.g001
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sequence for this gene fragment in E. coli were not successful owing
to plasmid instability (David Lanar, WRAIR, personal commu-
nication). The same was also true for the LSA-NRC
E gene, a
synthetic gene that was ‘‘codon optimized’’ by substituting with
codons that are used most frequently in E. coli proteins [26]. For
this latter construct, plasmid loss was especially problematic during
exponential growth phase, suggesting that the expression of the
codon optimized protein induced a host cell stress response. On
the other hand, the synthetic gene designed by using codon
harmonization (LSA-NRC
H) yielded a dramatic increase in
expression levels when compared with LSA-NRC
E (Fig. 6, I3hrs).
The purified protein yield for LSA-NRC
H was 8 mg/g wet cell
paste (Table 1). The protein produced from this codon
Table 1. Summary of Protein Expression Levels, Protein Yield, and Synonymous Codon Changes for the Constructs Described in
this Study
aExpression Level Purified Protein Yield
% of total protein (mg/g cell paste) Synonymous Codon Changes
Protein WT Gene CH Gene WT Gene CH Gene # codons # changes
FMP003 Not Detected Not Detected Not Detected 0.07
b 354 1
FMP010 Not Detected ,10% Not Detected 4
b 354 244
MSP142-3D7.2 2% ,10% 0.8
b 3 375 246
MSP142-Camp.2 Not Detected ,10% ND 12 373 245
LSA-NRC
H Not Detected ,10% ND 8
b 443 288
aEvaluated by densitometry of PAGE Gels Stained with Coomassie Blue R-250





Figure 2. Comparison of MSP142 (FVO) expression from plasmids encoding either wild type or the FMP003 gene by SDS-PAGE and
Coomassie Blue staining or Western Blotting. Panel A, Coomassie Blue stained gels at the time of induction (U) or 3 hours post induction (I 3hr);
Panel B, Western blots at the time of induction (U) or 3 hours post induction (I 3hr); Panel C, Coomassie Blue stained gels of protein following affinity
purification on Ni
+2-NTA chromatography. Arrows indicate migration of FMP003.
doi:10.1371/journal.pone.0002189.g002
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the problem of plasmid loss during exponential growth was
resolved. These results further support the hypothesis that the
LSA-NRC
E and LSA-NRC
H protein products fold differently
when expressed in E. coli and that the expression of LSA-NRC
H
protein did not induce a deleterious host cell stress response.
Discussion
The recent findings that genetic polymorphisms reflecting
synonymous codon substitutions are not ‘‘silent’’ and are
implicated in the development of various disease states mediated
through splicing defects refutes the long held dogma that
synonymous mutations are neutral [28–30]. Even a single
synonymous codon substitution within a coding region can lead
to proteins with altered substrate specificities [2] or enzymatic
activities [1], indicating significant changes in protein structure.
Thus, it is possible that subtle modulation of nucleotide sequence
may also serve to regulate protein structure and function, and such
sequence may have experienced evolutionary pressure to produce
fully functional proteins. Clearly, the present findings portend
problems in the area of applied biotechnology for heterologous
protein expression from distantly related organisms with disparate
codon bias. Consequently, we have developed an algorithm that
adjusts the tRNA isoacceptor availability found in the natural host
to that of the expression host; this may be needed to provide
optimal translational kinetics in the expression host.
The basic concepts underlying the ‘‘codon harmonization’’
algorithm are derived from evidence provided in Thanaraj, et
al, where codon usage frequency patterns from E. coli proteins
having known structures werea n a l y z e d[ 2 2 ] .T h e ys h o w e d
empirically that lower frequency codon preferences (rare
codons) tend to cluster within the regions of mRNA that encode
the link/end segments that separate elements of higher ordered
structure . These segments are approximately fifteen residues
long and are encoded by clusters of infrequently-used codons
[22,31] that are separated by 1–10 codons [23]. As few as two
consecutive infrequently used codons can reduce the steady-
state density of ribosomes on mRNA [32]. Slowing ribosomal
transit-time through such regions may allow concurrent
translation and acquisition of ordered structure by a structural
element, and this would be completed prior to the synthesis of
the next element.
Studies of the prokaryotic ribosomal tunnel during protein
synthesis support its role as an active modulator of nascent peptide
secondary structure formation [33]. High-resolution electron
micrographs of the 70S ribosome from E. coli show that the 50S
subunit contains a bifurcating tunnel that is 85A ˚ to 110A ˚ in length
as measured from the amino peptidyl transferase center to the exit
site on the distal surface [34,35], which can accommodate nascent
peptides of 30 to 72 amino acids, depending on secondary protein
structure [7]. The diameter of the tunnel is sufficiently large to
Figure 3. Comparison of expression levels of (WT), FMP003,
and FMP010 proteins. Total E. coli cell lysates were separated by
SDS-PAGE followed by staining with Coomassie Blue at either the time
of induction (U) or 3 hours post induction (I 3hr) with 0.1 mM IPTG. The
arrow indicates the migration of MSP142 protein.
doi:10.1371/journal.pone.0002189.g003
Figure 4. Solubility of the FMP010 protein product. U, lysate
from uninduced cells; I3hr, lysate prepared 3 hours after induction with
0.1 mM IPTG; f1, 30,0006g supernate from induced cell lysate; f2,
30,0006g pellet from induced cell lysate; f3, 100,0006g supernate of
30,0006g supernate; f4, 100,0006g pellet of 30,0006g supernate,. The
arrow indicates the migration of FMP010.
doi:10.1371/journal.pone.0002189.g004
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the ribosomal surface, which is 25–30A ˚ in diameter, appears to
accommodate chaperones, such as Trigger Factor [36,37], which,
as necessary [38], can interact with partially folded nascent
polypeptides to promote their complete folding. This may serve to
shield them from proteolysis prior to complete structure formation
as they are extruded from the tunnel [39].
The benefits derived by this rational process of codon
substitution are most dramatically shown by our limited
mutagenesis approach to create a single targeted synonymous
codon replacement for I141 within the sequence encoding a
putative link/end segment contained with MSP142 (FVO) protein.
Making this single base change, (i.e., to produce the FMP003
protein), increased yields of soluble product to approximately
70 mg protein/g of wet cell paste, this being at least ten-fold over
what was achieved with the native sequence. The MSP142
FMP003 antigen was subsequently produced under GMP
conditions and shown to be highly immunogenic and efficacious
against malaria challenge in an Aotus monkey study [25]. However,
the yield of FMP003 protein was too low to be of practical use for
vaccine development. Therefore we decided to ‘‘harmonize’’
codons throughout the entire gene sequence for MSP142 (FVO),
producing FMP010, and obtained a sixty-fold increase in
expression over the level that was detected for FMP003.
Expression levels for soluble protein from the codon harmo-
nized MSP142 3D7.2 and MSP142 Camp.2 genes equaled the
levels produced for FMP010. Our successes with the -FVO and -
Camp alleles are notable, as we detected no recombinant protein
when the native P. falciparum gene sequences were used for E. coli
expression. Thus, this approach has overcome a practical barrier
and recombinant proteins for these three genes are currently being
evaluated in pre-clinical studies to determine their vaccine
potential.
In addition to showing that the FMP003 protein produced a
strong malaria protective effect in vaccinated monkeys [25], we
observed that FMP010 induced antibodies that inhibit malaria
parasite growth in vitro at levels comparable with FMP003 (data
not shown). Such antibodies are known to be directed to important
conformational epitopes in the antigen [40,41]. Details for the pre-
clinical evaluation for FMP010 will be described elsewhere.
The improved expression of soluble protein was not a
consequence of simply changing the G/C ratio in the P. falciparum
target genes. As we show here with the LSA-NRC
E gene fragment,
codon optimization, or synonymously substituting high frequency
codons throughout the gene, for expression in E. coli allowed for
the production of very little protein. Codon harmonization
rectified this problem by preventing plasmid loss during
exponential growth, which suggests that the LSA-NRC
E expres-
sion product induced a deleterious host cell response. The MSP142
proteins from the FVO and 3D7 strains P. falciparum have been
expressed at high levels in E. coli from codon optimized genes, but
these proteins were insoluble and required refolding in vitro
[42,43].
Codon harmonization appears to offer excellent prospects for
design and expression of heterologous proteins, at least in E. coli;
whether or not it will be useful for other expression hosts remains
Figure 5. Comparison of expression levels of wild type (WT) and full gene codon harmonized (CH) MSP142 gene fragments from
3D7 and Camp strain P. falciparum: U, cell lysates from uninduced cells; I 3hr, lysate prepared 3 hrs post induction, respectively, after
induction with 0.1 mM IPTG. Samples were separated by SDS-PAGE and stained with Coomassie Blue. Panel A; MSP142 (3D7): expression of wild
type (WT) and codon harmonized MSP142 3D7.2 (CH) genes respectively. Panel B; expression of codon harmonized MSP142 Camp.2 gene. The arrows
indicate the migration of MSP142.
doi:10.1371/journal.pone.0002189.g005
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improve reliability of functional protein expression, this approach
may represent a paradigm shift for heterologous protein
expression, with important consequences for both structural
biology and biotechnology. However, one may anticipate that
control mechanisms other than the availability of tRNA
isoacceptor molecules can also affect co-translational folding
under different growth conditions or at different stages in the cell
cycle. The studies presented here underscore the importance of
continuing to achieve general solutions to problems of heterolo-
gous protein expression. Advances based on integration of
proteomic and genomic analysis may not be fully realized until
the target genes and the synthetic potential of the expression
organism are completely integrated; failing to achieve such a
balance may leave many potential vaccine and biopharmaceutical
products undiscovered.
Materials and Methods
Algorithm for Codon Harmonization
Design of synthetic genes with this algorithm requires two major
steps: identifying and recoding putative link/end segments,
followed by the recoding of other areas of the gene. The
identification of transcript regions that are likely to be translated
slowly requires a means to predict such segments. We first marked
residues that were one of the ten amino acids (Tyr, His, Trp, Ile,
Leu, Val, Ser, Thr, Pro, and Cys) that appear most frequently in
unstructured regions of E. coli proteins whose structures are known
[20]. Second, we determined the frequency with which every
residue’s respective codon is used in the native expression host (in
this case P. falciparum) as a percentage of all isoacceptors that can
encode that residue. Third, we selected a reference level that
defined low codon usage frequency in the native expression host;
initially this reference level was selected to be 15%. Fourth, we
marked the residues that both were on the list of ten residues that
appear most frequently in unstructured protein regions and were
determined to have codon usage rates less that the selected
reference level. Fifth, we inspected the results and counted the
number of regions that contained discrete clusters of infrequently
used codons. The optimal number of discrete clusters was
calculated to be equal to the len/30 where len is the number of
residues in the protein [20]. Steps 3–5 of this process were
reiterated, selecting a lower or higher reference frequency to
decrease or increase the sensitivity for optimizing the number of
infrequent codon clusters detected. Occasionally we identified
codons that were potential sites for translational pausing, but were
isolated rather than occurring as part of a cluster. In such a case
the P. falciparum codon was replaced with the E. coli codon that
most closely matched its frequency of usage. For this work, the
final iteration of the algorithm used an expression host codon
frequency reference value of 11%.
After identifying and harmonizing the usage frequencies of
critical codons in the putative link/end segments, the rest of the
gene is harmonized by selecting synonymous codons from the
heterologous expression host having usage frequencies that best
reflect the usage frequencies found for the native gene in the native
expression host; the selection logic is as follows: preferably equal
to, but if not available then the nearest greater than or less than.
Construction of Expression vector pET(K)
A multi-step cloning strategy was used to generate the final
expression vector, pET(K) from a precursor known as pET(AT)
[44]. Elimination of bla gene expression from pET(AT) was
achieved by excising the transcriptional and translational regula-
tory region with DraI (New England Biolabs, Beverly, MA) and
SspI (Roche, Indianapolis, IN) and re-ligating the ends, producing
pET(T), which confers tetracycline resistance. The pET(K) was
prepared from linearized pET(T), which was prepared by
digesting with Tth111I (New England Biolabs), treating with T4
DNA polymerase (Roche) to generate blunt ends and digesting
with SapI (Roche). The kan gene was isolated from the
pZE2.1PAC.4 vector [45] by digesting with AatII (Roche) and
SacI (Roche), and a blunt ended insert was prepared by treating
with T4 DNA Polymerase (Roche). Restriction mapping of
pET(K) showed that the kan coding sequence is on the plus strand.
Design, preparation and cloning of the synthetic gene
fragments
1. Site-directed mutagenesis for FMP003: The codon
harmonization algorithm was applied to the gene fragment
encoding MSP142 from the FVO strain of P. falciparum (GenBank
accession no. L20092). A single synonymous codon change,
associated with a predicted link/end segment from the N-terminal
portion of the protein (codon 141 (Ile); bp 423 (C-.A), was
selected for harmonization. Mutagenesis, cloning and expression
of this synthetic gene fragment, defined as FMP003 has been
described elsewhere [25].
Figure 6. Evaluation of expression levels for the E. coli codon
optimized LSA-NRC
E (3D7) and full gene codon harmonized
LSA-NRC
H (3D7). Total E. coli cell lysates were separated by SDS-PAGE
followed by staining with Coomassie Blue at the time of induction (U)
and 3 hours post induction (I 3hr) with 0.1 mM IPTG. The arrow indicates
the migration of LSA-NRC.
doi:10.1371/journal.pone.0002189.g006
Harmonization of Expression
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synthetic gene sequence for the MSP142 FVO synthetic gene
fragment or FMP010 (GenBank Accession no. DQ926900)
was developed by applying the codon harmonization algorithm
over the entire gene sequence. For gene synthesis, consecutive
pairs of complementary oligonucleotides (each 50–60 bases,
having 12–13 bases of unpaired sequence on the 59 ends) were
used to prepare four separate larger segments by using sequential
PCR steps. After TA cloning and transformation of One Shot
TOP 10 supercompetent cells (Invitrogen, Carlsbad, CA) using
ampicillin resistance, transformants were isolated and inserts were
sequenced to confirm all codon modifications. Each of the four
segments of ,300 nt contained unique restriction enzyme sites at
their termini, which allowed final assembly: fragment 1, 59 NdeI-
39 HincII; fragment 2, 59 HincII-39 BsrG; fragment 3, 59 BsrG I–
39 BstBI; fragment 4, 59 BstBI–39XhoI. The assembled MSP142
fragment (1130 nt) was cloned into the TA vector pCR 2.1
(Invitrogen), producing pCR 2.1-MSP142 FVO, and transformants
were isolated and verified by DNA sequencing. The MSP142 FVO
insert was excised from pCR 2.1-MSP142 FVO by digesting with
NdeI and XhoI, the insert was purified on a 1% agarose gel, and
cloned into the final pET(K) expression vector also prepared with
NdeI and XhoI (Veritas, Inc., Rockville, MD). Competent host
cells (One Shot TOP 10) were transformed to kanamycin
resistance, and restriction analysis was used to identify correct
clones for DNA sequencing. For expression, the plasmid was used
to transform the BL21-DE3 expression host (Novagen, Milwaukee,
WI).
3. Full codon harmonization of the MSP142 3D7.2 gene
fragment: The sequence for the synthetic MSP142 3D7.2 gene
fragment (GenBank Accession no. DQ926901) was developed
by applying the full codon harmonization algorithm. The gene was
constructed by using PCR amplification in conjunction with
proprietary protocols (Retrogen, Inc., San Diego, CA). The
amplified DNA was inserted into the pCR-Blunt vector (Invitro-
gen) creating the vector pCR 2.1-MSP142 3D7.2. Both strands of
the pCR 2.1-MSP142 3D7.2 insert were verified by sequencing
using an ABI 377 automated sequencer, and confirmed to be
correct. The insert was excised from the plasmid by digesting with
NdeI and NotI, purified on a 1% agarose gel, and subcloned into
the final pET(AT) expression vector, which was also prepared by
digesting with NdeI and NotI. The plasmid was designated
pET(AT) MSP142 3D7.2. BL21-DE3 transformants were selected
on ampicillin, and authenticity of the MSP142 insert within each
plasmid was verified by sequencing purified plasmid.
4. Full codon harmonization of MSP142 Camp gene
fragment: The Camp allele of MSP142 is a chimera of the 3D7
and FVO alleles, and was made by splicing AlwNI (New England
Biolabs) fragments corresponding to the 59end and 39end of the
codon harmonized 3D7 and FVO genes, respectively. Thus,
pET(AT) MSP142 3D7.2 digested with Alw NI and depho-
sphoryalated with shrimp alkaline phosphatase (Roche) provided
the 59 end of the gene, while the plasmid encoding FMP010 was
digested with Alw NI provided the 39 end of the gene. Vector and
insert were gel purified using QIAEX II (QIAGEN, Valencia, CA)
and ligated using T4 DNA ligase (Roche). Ligations were used to
transform electrocompetent B834 DE3 bacterial cells (Novagen) to
tetracycline resistance, producing an intermediate clone designat-
ed pET(T) MSP142 Camp.2; this cloning eliminated ampicillin
resistance from the vector. The final expression plasmid, pET(K)
MSP142 Camp.2, was prepared by digesting both the insert and
pET(K) vector DNA’s with NdeI and NotI, the digested DNA’s
were gel purified, ligated and transformed into BL21-DE3.
Colonies were screened for correct inserts using DNA restriction
digestion and analyzed 1% agarose gels stained with ethidium
bromide. Authenticity of the MSP142 insert was verified by
sequencing purified plasmid (GenBank Accession no.
DQ926902).
5. Codon harmonized LSA-NRC
H gene fragment. A
codon harmonized synthetic gene was comprised of fragments
from the N-terminus (residues 28-154) and the C-terminus
(residues 1630-1909) as well as two 17 amino acid repeats of
LSA-1 of the P. falciparum 3D7 clone (GeneBank ID no.
A45592). The molecular construction of the LSA-NRC
H
synthetic gene (GenBank Accession ID no. AY751501) and
its expression from the pET(K) expression vector have been
described elsewhere [26].
6. Codon optimized LSA-NRC
E gene fragment. A
synthetic gene encoding the same protein sequence as described
above for the LSA-NRC
H was designed based on using the most
abundant codons associated with highly expressed proteins in E.
coli [46]. The gene was synthesized commercially (Retrogen, San
Diego, CA), cloned and verified as described for the MSP142 (3D7)
gene fragment above. The synthetic gene was ligated into the NdeI
and NotI sites of pET(K) to prepare the expression construct
pET(K) LSA-NRC
E. The recombinant plasmid was amplified by
transforming E. coli DH5a using kanamycin resistance, and the
gene insert was verified by sequencing both DNA strands. For
expression of the LSA- NRC
E protein, the plasmid was used to
transform E. coli Tuner (DE3) (Novagen) using kanamycin
resistance in the presence of 1% glucose.
Expression
Shake flasks containing 100 mL of phytone-based super broth
and 0.5% glucose (all MSP142 constructions) or Select APS
Superbroth medium (Difco, Becton Dickinson, Sparks, MD) and
1% glucose (all LSA1 constructions) were inoculated with 0.1 mL
of cryopreserved cells and incubated in a shaking incubator at
175 rpm and 30uC (all MSP142 constructions) or 37uC (all LSA-
NRC constructions) overnight for 10–14 hours. Cultures also
contained the appropriate antibiotic for the clone (100 mg/ml
ampicillin for MSP142 3D7 and 50 mg/ml kanamycin for MSP142
Camp and MSP142 FVO (FMP010), and 35 mg/ml kanamycin for
all LSA-NRC constructions). The overnight cultures were used to
inoculate 10 L fermentors filled with the media and antibiotics
described above for each clone, and the cultures were fermented at
the appropriate temperatures with either 400 or 600 rpm of
agitation to an optical density at 600 nm of 4–7 OD (all MSP142
constructions) or 8–10 (all LSA-NRC constructions). In all cases,
protein expression was induced for 2–3 hours by adding dioxane-
free IPTG (Gold Biolabs, St. Louis, MO) to a final concentration
of 0.1 mM. Bacteria were harvested by centrifugation at 4uC,
15,000 rpm and the cell paste was stored frozen at 280610uC.
Evaluation of protein expression and immunoblotting
Protein expression was evaluated either by staining with
Coomassie Blue R250 (Bio-Rad, Richmond, CA) after SDS-
PAGE [47] of whole cell extracts, or by western blotting of
partially purified proteins. In either case, proteins were separated
under nonreducing conditions. Proteins were electrophoresed with
Tris-Glycine buffering (Invitrogen), on 4–20% gradient gels.
Whole cell extracts were prepared by extracting 0.5 OD600 of
cells with SDS-PAGE sample buffer. For protein purifications,
frozen cell paste was thawed and cells were lysed by micro-
fluidization (Model M-110Y, Microfluidics Corp. Newton, MA) as
described previously [44]. For western blotting, MSP142 proteins
were detected by probing with polyclonal rabbit anti-MSP-142
[44]. Western blots were prepared by using nitrocellulose
Harmonization of Expression
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NH) which were subsequently blocked using 5% nonfat dry milk
and 0.1% Tween 20 in PBS, pH 7.4. The secondary antibodies
were anti-rabbit IgG (Fc) alkaline phosphatase conjugates
(Promega, Madison, WI) and reactions were detected with
nitro-blue tetrazolium (NBT) and 5-bromo-4-chloro-3-indolyl
phosphate (BCIP) (Sigma Chemicals) in 100mM NaCl, 5mM
MgCl2, 100mM Tris-HCl, pH 9.5. All antibodies were diluted
into phosphate buffered saline, pH 7.4 containing 0.1% Tween
20, and the same buffer was used for all washing steps. MSP142
proteins were further evaluated for maintenance of structure by
probing western blots with six different conformation-depen-
dant mAbs [41]. These studies required at least partial
purification of the expressed proteins by chromatography on
Ni
2+ chelate (Ni-NTA Superflow, QIAGEN, Valencia, CA) in
order to allow for epitope stabilization by formation of intra-
molecular disulfide bridges within the C-termini of the
molecules [25,44].
Supporting Information
Table S1 Illustration of Codon Harmonization. Example
showing application of the codon harmonization algorithm over
a segment of MSP1-42 FVO coding sequence.
Found at: doi:10.1371/journal.pone.0002189.s001 (0.04 MB
XLS)
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